Withdrawn study aimed to predict suicide risk with brain scans and psychedelics
NCT ID NCT07484906
First seen Mar 24, 2026 · Last updated May 23, 2026 · Updated 8 times
Summary
This study planned to enroll 150 people at different risk levels for self-harm to see if brain scans and blood tests could predict who is at high risk and who responds best to treatments like neurofeedback, magnetic stimulation, and psilocybin therapy. However, the study was withdrawn before any participants were enrolled, so no results are available.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SUICIDAL IDEATION are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.